Delivery Order SPE2DB20D1100-SPE2DB25FE0SV
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,657.94 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The award represents a child contract under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a ceiling value of $1,303.59. This firm fixed-price delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a direct fulfillment from AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and performance will take place at the...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $36,127.45 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,107.15 contract is for the delivery of Prograf 1 mg capsules, a specialty medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a $39,414.93 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for a quantity of 100 count Prograf 5 mg capsules, which are likely immunosuppressant medications used to prevent organ rejection in transplant patients. The order has a completion date of September 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for Prograf 1 mg capsules. The contract has a ceiling value of $1,454.98 and is a firm fixed price contract type. The place of performance is Conshohocken, Pennsylvania. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,565,736 units of the prescription medication Prograf 1 mg capsules. The order is a firm fixed-price contract valued at $15,062.59 and will be delivered by September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of the pharmaceutical product PROGRAF 1 MG CAPSULE. The $1,640.00 order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a broad...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0SVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $106,966.00 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price, competitively awarded contract, with no set-aside designation, was finalized on September 22, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical supply chain for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. This delivery order for Prograf—an immunosuppressant medication commonly used in transplant patients—reflects AmerisourceBergen's ongoing role in supplying essential pharmaceutical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible and comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.0k | 9/22/25 |